Endocrine-related adverse events associated with targeted treatment and immune checkpoint blockage in hematological malignancies
Hematology in Clinical Practice · 2023
DOI: 10.5603/hcp.2023.0003 ↗Kurz gefasst
Fachartikel in der Zeitschrift Hematology in Clinical Practice, 2023. Verfasst von Małgorzata Bobrowicz und 4 weiteren Autor:innen.
Themen: Patientensicherheit
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Bobrowicz, M., Góralska, M., Kusowska, A., Skowrońska-Szcześniak, A., & Bednarczuk, T. (2023). Endocrine-related adverse events associated with targeted treatment and immune checkpoint blockage in hematological malignancies. Hematology in Clinical Practice. https://doi.org/10.5603/hcp.2023.0003
Vancouver
Bobrowicz M, Góralska M, Kusowska A, Skowrońska-Szcześniak A, Bednarczuk T. Endocrine-related adverse events associated with targeted treatment and immune checkpoint blockage in hematological malignancies. Hematology in Clinical Practice. 2023. doi:10.5603/hcp.2023.0003
BibTeX
@article{Bobrowicz2023,
author = {Bobrowicz, Małgorzata and Góralska, Magdalena and Kusowska, Aleksandra and Skowrońska-Szcześniak, Anna and Bednarczuk, Tomasz},
title = {Endocrine-related adverse events associated with targeted treatment and immune checkpoint blockage in hematological malignancies},
journal = {Hematology in Clinical Practice},
year = {2023},
doi = {10.5603/hcp.2023.0003}
}
EUVIMED